Dose normalization [Study Per­for­mance]

posted by Relaxation  – Germany, 2021-05-27 15:29 (364 d 22:37 ago) – Posting: # 22373
Views: 1,009

» will not receive the actual dose, but will receive a smaller dose when assessing BD / BE (2x2x2) design)?

Hello yura.

I am sorry, but I am a little bit in a hurry and just wanted to start the answers here with one single comment.
As you are in a cross-over situation and assuming that the dose (BSA) of a subject will not change between periods, there is no need for a dose-adjustment with regard to the treatment comparison. Or the other way around: as you compare intraindividually the dose-adjustment would cancel out anyway.

Best regards!

Complete thread:

UA Flag
 Admin contact
22,108 posts in 4,630 threads, 1,567 registered users;
online 6 (0 registered, 6 guests [including 2 identified bots]).
Forum time: Friday 14:06 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz